Grant: Alliance Grants
University of Toronto
$71,738.00
Cell biology of Leishmania infections in phagocytes
FY 2024-25
Summary
The parasitic disease leishmaniasis is the third deadliest neglected tropical disease (NTD). Leishmaniasis symptoms range from localized skin to disseminated infections. The latter, if not treated, leads to organ damage and death. Due to a lack of research, no vaccines or antiparasitic drugs exist to prevent leishmaniasis. To address this problem, we have established an international collaboration with colleagues at Fiocruz Bahia, Brazil- a world renowned institute for NTDs- to investigate how Leishmania takes over our cells to cause disease.
Leishmaniasis is caused by different species of Leishmania, parasites transmitted to humans and other animals through the bite of some sandflies. Although the sandfly species that carry Leishmania are not currently present in Canada, leishmaniasis affects Canadians travelling to endemic regions, mainly Africa, Asia and Latin America, as well as temporary immigrants and newcomers arriving from those areas. Furthermore, Leishmania-infected dogs imported into Canada transmit the disease to domestic dogs and humans. The multiple clinical forms of Leishmaniasis may reflect the various ways in which Leishmania species interact with our immune system. Phagocytes are specialized cells in our defense system that trap and kill microbes to prevent disease. Leishmania can infect and modify phagocytes' behavior turning them into shuttles that distribute the parasite within the organism. Our proposed research plan seeks to understand the molecular and cellular mechanisms underlying Leishmania-phagocyte interactions and its impact on the various manifestations of leishmaniasis. This international collaboration will facilitate the study of Leishmania species isolated from different clinical forms of leishmaniaisis from endemic areas in Brazil. We expect to generate new knowledge that will foster the development of effective treatments to control leishmaniasis.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
592352-2023
Name nom
Terebiznik, Mauricio MR
Department département
Biological Sciences (Scarborough)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
71738
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Cell biology of Leishmania infections in phagocytes
Keywords
dissemination; host-pathogen interactions; intracellular trafficking; leishmania parasites; leishmaniasis; macrophages; neglected tropical diseases; organelle remodeling; phagocytes; phagocytosis
Application summary
The parasitic disease leishmaniasis is the third deadliest neglected tropical disease (NTD). Leishmaniasis symptoms range from localized skin to disseminated infections. The latter, if not treated, leads to organ damage and death. Due to a lack of research, no vaccines or antiparasitic drugs exist to prevent leishmaniasis. To address this problem, we have established an international collaboration with colleagues at Fiocruz Bahia, Brazil- a world renowned institute for NTDs- to investigate how Leishmania takes over our cells to cause disease.
Leishmaniasis is caused by different species of Leishmania, parasites transmitted to humans and other animals through the bite of some sandflies. Although the sandfly species that carry Leishmania are not currently present in Canada, leishmaniasis affects Canadians travelling to endemic regions, mainly Africa, Asia and Latin America, as well as temporary immigrants and newcomers arriving from those areas. Furthermore, Leishmania-infected dogs imported into Canada transmit the disease to domestic dogs and humans. The multiple clinical forms of Leishmaniasis may reflect the various ways in which Leishmania species interact with our immune system. Phagocytes are specialized cells in our defense system that trap and kill microbes to prevent disease. Leishmania can infect and modify phagocytes' behavior turning them into shuttles that distribute the parasite within the organism. Our proposed research plan seeks to understand the molecular and cellular mechanisms underlying Leishmania-phagocyte interactions and its impact on the various manifestations of leishmaniasis. This international collaboration will facilitate the study of Leishmania species isolated from different clinical forms of leishmaniaisis from endemic areas in Brazil. We expect to generate new knowledge that will foster the development of effective treatments to control leishmaniasis.